As VEGF-targeted mAbs have failed to control disease in GBM, we argue that vascular normalization is not the sole factor to overcome treatment resistance of GBM, and other mechanisms may co-exist or even prevail upon targeting neoangiogenesis. Here, VEGFA is linked to glioblastoma.